Prescription drug · NDA
Zestril (Lisinopril) NDC 24979-239
Lisinopril 5 mg/1 · Tablet · Oral · Upsher-Smith Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 24979-239-07 | 24979023907 | 90 TABLET in 1 BOTTLE (24979-239-07)Marketed from Apr 25, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zestril
- Generic name (nonproprietary)
- lisinopril
- Active ingredients
- Lisinopril — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Upsher-Smith Laboratories, LLCNDC labeler code 24979
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019777
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)
- Identifiers
- Product ID 24979-239_7875efff-59e3-4f68-84c5-e3c9c16d6a3cSPL ID 7875efff-59e3-4f68-84c5-e3c9c16d6a3cSPL set ID 838c2d78-d2d8-4981-9ec9-e50ef9e1a5d8RxCUI 104375, 104376, 104377, 104378, 197884, 205326, 206771, 213482, 311353, 311354, 314076, 314077UNII E7199S1YWRUPC 0324979239071, 0324979241074, 0324979243078, 0324979240077, 0324979242071, 0324979238074
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N424979023907followed by a unit qualifier and the quantityPackage 24979-0239-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Zestril is an angiotensin converting enzyme (ACE) inhibitor indicated for: Treatment of hypertension in adults and pediatric patients 6 years of age and older ( 1.1 ) Adjunct therapy for heart failure ( 1.2 ) Treatment of Acute Myocardial Infarction ( 1.3 ) 1.1 Hypertension Zestril is indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. Control of high blood pr…
Excerpt only. Read the full label for complete information.
About NDC 24979-239
- What is NDC 24979-239?
- 24979-239 is the product NDC for Zestril (lisinopril), Lisinopril 5 mg/1 tablet, listed with the FDA by Upsher-Smith Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zestril (Lisinopril).
- What is the active ingredient?
- Lisinopril.
- Who is the labeler?
- Upsher-Smith Laboratories, LLC, NDC labeler code 24979. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zestril?
- 5 other product NDCs are listed under this name. See all Zestril NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zestril products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zestrillisinopril | Lisinopril 2.5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-238 | 24979-0238-07 |
| Zestrillisinopril | Lisinopril 10 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-240 | 24979-0240-07 |
| Zestrillisinopril | Lisinopril 20 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-241 | 24979-0241-07 |
| Zestrillisinopril | Lisinopril 30 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-242 | 24979-0242-07 |
| Zestrillisinopril | Lisinopril 40 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-243 | 24979-0243-07 |
Other NDCs under NDA 019777
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zestrillisinopril | Lisinopril 10 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-240 |
| Zestrillisinopril | Lisinopril 2.5 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-238 |
| Zestrillisinopril | Lisinopril 20 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-241 |
| Zestrillisinopril | Lisinopril 30 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-242 |
| Zestrillisinopril | Lisinopril 40 mg/1 | TabletOral | Upsher-Smith Laboratories, LLC | 24979-243 |